Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)

Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing–Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study)

Subcutaneous (SC) interferons beta (IFN-beta) are effective therapies for the treatment of relapsing–remitting multiple sclerosis (RRMS). Factors such as dosing schedule, needle intolerance/fatigue, and side effects may impact patient satisfaction with treatment. Improvement of patient satisfaction...

Full description

Bibliographic Details
Main Authors: Diego Centonze, Roberta Fantozzi, Fabio Buttari, Luigi Maria Edoardo Grimaldi, Rocco Totaro, Francesco Corea, Maria Giovanna Marrosu, Paolo Confalonieri, Salvatore Cottone, Maria Trojano, Valentina Zipoli
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Neurology
Subjects:
Peg-IFN beta-1a
multiple sclerosis
adverse event
adherence
treatment satisfaction
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.637615/full

Similar Items

Similar Items